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Abstract
 
The mechanisms that regulate B cell memory and the rapid recall response to antigen remain
poorly defined. This study focuses on the rapid expression of B cell memory upon antigen re-
call in vivo, and the replenishment of quiescent B cell memory that follows. Based on expres-
sion of CD138 and B220, we reveal a unique and major subtype of antigen-specific memory B
 
cells (B220
 
2
 
CD138
 
2
 
) that are distinct from antibody-secreting B cells (B220
 
1
 
/
 
2
 
CD138
 
1
 
) and
B220
 
1
 
CD138
 
2
 
 memory B cells. These nonsecreting somatically mutated B220
 
2
 
 memory re-
 
sponders rapidly dominate the splenic response and comprise 
 
.
 
95% of antigen-specific mem-
ory B cells that migrate to the bone marrow. By day 42 after recall, the predominant quiescent
memory B cell population in the spleen (75–85%) and the bone marrow (
 
.
 
95%) expresses the
B220
 
2
 
 phenotype. Upon adoptive transfer, B220
 
2
 
 memory B cells proliferate to a lesser degree
but produce greater amounts of antibody than their B220
 
1
 
 counterparts. The pattern of cellular
differentiation after transfer indicates that B220
 
2
 
 memory B cells act as stable self-replenishing
intermediates that arise from B220
 
1
 
 memory B cells and produce antibody-secreting cells on
rechallenge with antigen. Cell surface phenotype and Ig isotype expression divide the B220
 
2
 
compartment into two main subsets with distinct patterns of integrin and coreceptor expres-
sion. Thus, we identify new cellular components of B cell memory and propose a model for
long-term protective immunity that is regulated by a complex balance of committed memory
B cells with subspecialized immune function.
Key words: antigen-speciﬁc immunity • immunological memory • B lymphocyte memory • 
B lymphocyte subset • mice
 
Introduction
 
The memory B cell response is typically characterized by
the accelerated appearance of Ag-specific Ab in response to
specific rechallenge with Ag (1–3). It is useful to consider
Ag-specific memory B cell development in four broad
 
phases (4): (a) induction of B cell memory occurs within the
germinal center (GC)
 
1
 
 reaction; (b) maintenance of B cell
memory begins with the exit of long-lived memory B cells
 
from the GC reaction and maintains the memory B cell com-
 
partment in readiness for Ag rechallenge; (c) expression
 
 
 
of
B cell memory occurs upon Ag rechallenge and is an emer-
gent cellular and humoral activity focused on Ag clearance;
and (d) replenishment of the memory B cell compartment
 
after Ag rechallenge is critical for long-term protective
immunity. Although the systemic phenomenon of B cell
memory is readily demonstrated in vivo, the nature and ex-
tent of cellular heterogeneity in the Ag-specific memory B
cell compartment remains poorly resolved.
B cell memory is induced upon primary Ag challenge
and is thought to be a product of the GC reaction (5–8).
The specialized and dynamic microenvironment of the GC
reaction coordinates affinity maturation of Ag-expanded B
cells through reiterative cycles of somatic hypermutation
and Ag-driven selection (9–11). In this manner, GCs regu-
late Ag-specific clonal maturation and subsequent entry
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Abbreviations used in this paper:
 
 APC, allophycocyanin; BCR, B cell re-
ceptor; GC, germinal center; ELISPOT, enzyme-linked immunospot;
MFI, mean fluorescence index; NP, (4-hydroxy-3-nitrophenyl)acetyl;
NP-APC, NP-labeled APC; PI, propidium iodide; Rag-1, recombina-
tion activating gene 1; RT, reverse transcriptase; sIg, surface Ig; TEM,
transmission electron micrograph. 
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into the long-lived memory B cell compartment (12, 13).
The initiation and maintenance of the GC reaction de-
pends on a multitude of factors that have received a great
deal of recent attention (4). The regional organization in
the spleen before Ag stimulation (14–16) and chemokine-
driven lymphoid circuitry (17, 18) is vital to effective for-
mation of GCs. T cell help (19) and CD40–CD40 ligand
interactions greatly influence the initiation (20–22) and
function (23, 24) of the GC reaction. Although less is
known of the mechanisms that drive positive selection in
the GC reaction, native Ag clearly plays a role (25, 26) and
is most likely trapped within GC as immune complexes
(27–29). Nevertheless, positively selected Ag-specific B
cells that successfully exit the GC reaction constitute the
beginnings of the long-lived memory B cell compartment.
Affinity-matured memory B cells are maintained in vivo
in at least two different forms: memory response precursors
and long-lived Ab-secreting B cells (4). Memory response
precursors are typically defined as IgM
 
2
 
IgD
 
2
 
B220
 
1
 
 Ag-
binding B cells that do not secrete Ab until rechallenge
with Ag (13, 30, 31). These B220
 
1
 
 memory B cells can ex-
press mutated Ag receptors and are found in late primary
and secondary responses (9–11, 32–34). Long-lived Ab-
secreting B cells (35–37) can also be considered part of the
memory B cell compartment (38–40). These long-lived B
cells are characterized by their ability to spontaneously
secrete Ab directly ex vivo. They typically secrete high-
affinity Abs with evidence of somatic hypermutation and
Ag-driven selection in their expressed Ig (41, 42). Thus,
memory B cells are most reliably characterized as persistent
Ag-binding B cells that display evidence of somatic hyper-
mutation in their expressed Ig genes.
The murine model offers the greatest opportunity to
quantitatively analyze de novo memory B cell develop-
ment. An ideal response for direct ex vivo analysis of Ag-
specific B cells is the immune response in C57BL/6 mice
to the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP [43,
44]). NP-specific B cells can be visualized directly in situ
(9, 45, 46) or through NP binding by flow cytometry (11,
32–34, 41, 47, 48). The vast majority of NP-specific B cell
clones from a primary response express B cell receptors
(BCRs) with the V
 
H
 
186.2 H chain coupled to V
 
l
 
1
 
 L chain
(49, 50). Somatic mutation proceeds in the GC microenvi-
ronment (9, 10) and is seen in NP-specific B cells as early as
day 6 after initial priming (51). Most NP-binding cells
express mutated H and L chain genes by the end of the
second wk after priming and can be visualized upon Ag
rechallenge in vivo (9, 11, 32, 33). Direct access to NP-
specific B cells through flow cytometry provides a reliable
means to analyze NP-specific B cell memory directly ex
vivo.
This study focuses on the rapid expression of B cell
memory upon Ag recall, and replenishment of the quies-
cent memory B cell compartment. We identify three dis-
tinct subtypes of NP
 
1
 
IgD
 
2
 
 memory responders that
emerge rapidly upon Ag rechallenge and persist at different
levels into the quiescent memory compartment. All three
subtypes express somatically mutated 
 
l
 
1
 
 L chain genes,
 
with Ab-secreting activity found only in the B220
 
1
 
/
 
2
 
CD138
 
1
 
 compartment. Previously described B220
 
1
 
 mem-
ory B cells appear as a B220
 
1
 
CD138
 
2
 
 memory B cell sub-
set with the greatest proliferative capacity on adoptive
transfer with Ag. Upon Ag recall, the B220
 
1
 
 memory B
cells rapidly produce a third and major B220
 
2
 
CD138
 
2
 
memory B cell subset. This new B220
 
2
 
CD138
 
2
 
 memory
subset also expands rapidly on recall, dominates the NP-
specific memory response in both the spleen and bone
marrow, and persists long term to comprise the majority of
quiescent memory B cells. The B220
 
2
 
 memory compart-
ments are stable self-replenishing B cells with a high pro-
pensity to form Ab-secreting cells. The pattern of BCR
coreceptor expression suggests that these memory cells
have unique mechanisms for modulating Ag responses in
vivo. Two further subtypes of B220
 
2
 
 memory B cells can
be defined based on CD11b and surface Ig (sIg) isotype ex-
pression (CD11b
 
11
 
IgG
 
1
 
 and CD11b
 
1
 
IgE
 
1
 
). These studies
provide the first quantitative assessment of the extensive
cellular and functional heterogeneity within the Ag-specific
memory B cell compartment.
 
Materials and Methods
 
Isolation of NP-specific Memory B Cells.
 
6–10-wk old, specific
pathogen-free, female C57BL/6 mice (The Jackson Laboratory)
were immunized with 400 
 
m
 
g NP-KLH intraperitoneally in Ribi
adjuvant (Ribi ImmunoChem Research). At least 8 wk after the
initial injection, the animals were rechallenged with an identical
immunization. The Duke University Institutional Animal Care
and Use Committee approved this study. Spleen and bone mar-
row were harvested at various time points, and single cell suspen-
sions were prepared as described previously (52, 53).
Cell suspensions were labeled for flow cytometry at 2.0 
 
3
 
 10
 
8
 
cells/ml on ice for 45 min with predetermined optimal concen-
trations of fluorophore-labeled mAbs (purchased from PharMin-
gen unless otherwise noted) or Ag and in combinations outlined
in each figure legend. The following Abs were used for staining
cells: Cy5PE-H129.19 (anti-CD4), Cy5PE–53-6.7 (anti-CD8),
Cy5PE-F4/80 (antimacrophage; Caltag Laboratories), Texas red
11.26 (anti-IgD), allophycocyanin (APC)-NP (4-hydroxy-5-
iodo-3-nitrophenyl), PE-281.2 (anti-CD138/syndecan), PE-6B2
(anti-CD45R/B220), PE-23G3 (anti-IgE; Southern Biotechnol-
ogy Associates), FITC-6B2 (anti-CD45R/B220), FITC–30-F11
(anti-CD45/leukocyte common Ag), FITC-1D3 (anti-CD19),
FITC-M1/70 (anti-CD11b/Mac-1), FITC–goat anti–mouse IgG
(Southern Biotechnology Associates), FITC-HM79b (anti-
CD79/Ig
 
b
 
), and FITC-JC5.1 (anti-
 
l
 
1
 
 L chain). After staining,
cells were washed twice in PBS with 5% FCS. Cells were then
resuspended in 2 
 
m
 
g/ml propidium iodide (PI) for dead cell ex-
clusion in PBS, with 5% FCS for analysis.
Samples were analyzed using a modified dual laser FAC-
Star
 
PLUS™
 
 (Becton Dickinson) capable of simultaneous seven pa-
rameter acquisition and fluorescence overlap compensation across
lasers. Files were acquired using CELLQuest™ software (Becton
Dickinson) and analyzed using FlowJo software (Tree Star). Pro-
files are presented as 5% probability contours with outliers.
 
Assay for Specific Ab.
 
Enzyme-linked immunospot (ELISPOT)
for detection of NP-specific IgG was performed as described pre-
viously (11, 34). 96-well multiscreen membrane filtration plates
(Millipore) were coated for 4 h with 50 
 
m
 
l/well of NP-BSA (25 
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m
 
g/ml) in PBS, washed, and incubated for 2 h with 100 
 
m
 
l of
RPMI 1640 supplemented with 5% FCS. Cells were sorted di-
rectly into the wells and incubated for 18 h at 37
 
8
 
C in 5% CO
 
2
 
.
The wells were washed before the addition of 50 
 
m
 
l/well of
horseradish peroxidase goat anti–mouse IgG (Southern Biotech-
nology Associates) for 4 h. ELISPOTs were developed using 100
 
m
 
l/well of filtered 3-1mino-9-ethyl carbazole substrate (Sigma
Chemical Co.) in 0.1 M sodium acetate buffer, pH 5.0, 0.03%
H
 
2
 
O
 
2
 
. The plates were washed with water, and positives were
scored manually using a dissection microscope. Each assay was
done in triplicate from at least three separate animals.
ELISA for detection of NP-specific IgG was performed as de-
scribed previously (11, 33). Flexible U-bottomed 96-well plates
(Costar) were coated for 4 h with 50 
 
m
 
l/well of NP-BSA conju-
gate (25 
 
m
 
g/ml) and washed. Samples were added in PBS with
0.1% Tween 20, 0.3% (w/v) skim milk powder, and 1% FCS,
held at room temperature for 4 h, washed before the addition of
50 
 
m
 
l/well of horseradish peroxidase conjugates of goat anti–
mouse IgG (Southern Biotechnology Associates), and held for 4 h
before washing and the addition of 100 
 
m
 
l/well of enzyme sub-
strate 2,2
 
9
 
-azinobis(3-ethylbenzthiazoline) (Sigma Chemical) at
55 mg/ml in 0.1 M sodium citrate, pH 4.5, and 0.1% H
 
2
 
O
 
2
 
. Ab-
sorbance read at 405 nm.
 
Single Cell Repertoire Analysis.
 
cDNA synthesis was performed
as follows: single B cells with the appropriate surface pheno-
type were sorted for repertoire analysis using the automatic cell-
dispensing unit attached to the FACStar
 
PLUS™
 
 (Becton Dickin-
son) and Clone-Cyt™ software (Becton Dickinson). Each cell
was sorted into an oligo d(T)-primed 5 
 
m
 
l cDNA reaction mix-
ture as described previously (reference 53; 4 U/ml MLV reverse
transcriptase [RT; GIBCO BRL] with recommended 1
 
3
 
 RT
buffer, 0.5 nM spermidine [Sigma Chemical Co.], 100 
 
m
 
g/ml
BSA [Boehringer Mannheim], 10 ng/ml oligo d(T) [Becton
Dickinson], 200 
 
m
 
M each dNTP [Boehringer Mannheim], 1 mM
dithiothreitol [Promega], 220 U/ml RNAsin [Promega], 100
 
m
 
g/ml 
 
Escherichia coli 
 
tRNA [Boehringer Mannheim], and 1%
Triton X-100 set up in low-profile 72-well microtiter trays
[Robbins Scientific]), held immediately at 37
 
8
 
C for 90 min, and
then stored at 
 
2
 
80
 
8
 
C until further use.
 
Nested PCR.
 
First round of PCR: 2 
 
m
 
l of cDNA from each
single cell cDNA reaction was used in a 25-
 
m
 
l reaction to amplify
the 
 
l
 
 L chain. The first-round PCR reaction mix consisted of
2 U/ml Taq polymerase with the recommended 1
 
3
 
 reaction buffer
(Promega), 0.1 mM of each dNTP (Boehringer Mannheim), 1 mM
MgCl
 
2
 
, 0.8 
 
m
 
M primer LAMext3(sense) (5
 
9
 
-TACTCTCTCTC-
CTGGCTCTCAGCTC-3
 
9
 
), and 0.8 
 
m
 
M primer LAMext3(anti)
(5
 
9
 
-GTTGTTGCTCTGTTTGGAAGGCTGG-3
 
9
 
). Each reac-
tion set begins with 95
 
8
 
C for 5 min, then 40 cycles of 95
 
8
 
C for 15 s,
50
 
8
 
C for 45 s, and 72
 
8
 
C for 90 s, and ending with 72
 
8
 
C for 5 min.
Second round of PCR: 1 
 
m
 
l of the first-round PCR product was
used for an additional 25-
 
m
 
l amplification reaction using primers
nested medially to the primers used in the first round of PCR
(2 U/ml Taq polymerase with the recommended 1
 
3
 
 reaction
buffer [Promega], 0.1 mM of each dNTP [Boehringer Mannheim],
1 mM MgCl
 
2
 
, 0.8 
 
m
 
M primer LAM.sens[int] [5
 
9
 
-CCATTTC-
CCAGGCTGTTGTG-3
 
9
 
), and 0.8 
 
m
 
M primer LAM.anti(int)
(5
 
9
 
-CTCCATACCCTGAGTGACAG-3
 
9
 
]). Each reaction set
begins with 95
 
8
 
C for 5 min, then 40 cycles of 95
 
8
 
C for 15 s, 50
 
8
 
C
for 45 s, and 72
 
8
 
C for 90 s, and ending with 728C for 5 min. At
least 2 negative cDNA samples were processed per 10 single cell
samples. The negatives were interspersed with positives to control
for contamination during sample preparation.
DNA Sequencing. 5 ml of second-round PCR product was
run on a 1.5% agarose gel to screen for positives (single bands of
the right size). PCR product was then separated from primers us-
ing a CL-6B Sepharose (Amersham Pharmacia Biotech) column.
The PCR product was then directly sequenced (4 ml of PCR
product, 4 ml Dye Terminator Ready Reaction Mix [Perkin
Elmer Corp.], 1.6 pmol primer [LAM.seq 59-GGCTGTTGT-
GACTCAGGAAT-39]) using a linear amplification protocol for
25 cycles of 968C for 10 s, 508C for 5 s, and 608C for 4 min on a
9600 GeneAmp PCR system (Perkin Elmer Corp.). Samples
were separated on a 6.5% acrylamide gel after ethanol precipita-
tion of sequencing reaction products, run on an ABI 373 se-
quencing system, and processed using ABI Prism sequence 2.1.2
for collection and analysis (Perkin Elmer Corp.).
Adoptive Transfer. Unfractionated spleen cells (4 3 107) from
C57BL/6 mice 4 or 42 d after secondary immunization with 400
mg NP-KLH in Ribi adjuvant were injected in 100 mL PBS into
the tail vein of 6–10-wk-old C57BL/6 recombination activating
gene 1 (Rag-1)–deficient mice (The Jackson Laboratory), with or
without intraperitoneal injection of 50 mg NP-KLH (no adju-
vant). For “exclusion transfer,” 5–8 3 106 spleen cells were
sorted by flow cytometry to exclude any NP1IgD2 cells and all
CD1381 cells and then injected as a transfer of “background”
cells (NP2 spleen). 2–6 3 104 purified PI2CD42CD82F4/
802NP1IgD2CD1382 B cells that were either B2201 or B2202
were added to 5–8 3 106 NP2 spleen cells. Purity of sorted pop-
ulations was then reanalyzed before and after mixing with the
NP2 spleen cells immediately before transfer with purities of
.95–98% for the subsets transferred. Spleens were harvested
from the recipient mice 5 d after transfer and processed as de-
scribed above.
Results
NP-specific Memory B Cells in the Spleen. Using flow cy-
tometry, we quantify directly the Ag-binding B cells from
C57BL/6 mice immunized with the hapten-protein conju-
gate NP-KLH in the Ribi adjuvant system. The change to
Ribi adjuvant (nonpolarizing for T cell help) for both
priming and recall induces NP-specific Ab of all IgG iso-
types and IgE to high levels in the serum of immunized
mice (data not shown). We first focus on the emergent
splenic memory response during the first 2 wk after intra-
peritoneal rechallenge with Ag. Ag-binding cells were
clearly visualized in the spleen and bone marrow as PI2
CD42, CD82, and F4/802 cells that have lost sIgD and
bind NP-labeled APC (NP-APC; Fig. 1, A iii). Ag-specific
expansion of NP1IgD2 cells was significant by day 3 in the
spleen, and rapidly reaches peak levels by day 4 (Fig. 1, A
iv, top). This rate of NP-specific cellular expansion is 3–4 d
faster than seen after initial priming 8 wk earlier (11; our
unpublished results). Adjuvant-only controls indicate that
NP-binding cells only emerge in response to the presence
of NP-KLH (Fig. 1 A). Similar results were obtained using
carrier alone and an irrelevant protein (data not shown; 11).
Decline in the number of NP1IgD2 cells in the spleen is
already evident by the end of the second wk, but is clearly
diminished by day 42 after recall (Fig. 1 A). The day 42
time point is representative of the quiescent memory com-
partment when the active GC reaction and the exaggerated1152 Antigen-specific B Cell Memory
humoral recall response have both resolved. The replen-
ished memory compartment at this time point contains at
least 100-fold more NP-specific cells than were detectable
before rechallenge. Therefore, accelerated Ag-specific cel-
lular expansion and the development of a larger quiescent
memory compartment are two major cellular consequences
of Ag rechallenge.
Three Phenotypically Distinct Memory B Cell Subsets in the
Spleen. Using five-color flow cytometry, we can directly
phenotype the NP1IgD2 compartment. Because cell sur-
face phenotype can provide clues to function, we initially
subtype the NP-specific cells using Abs to B220 (6B2,
anti–B cell isoform of CD45R) and CD138 (281.2, anti-
syndecan). A major subset of B2201/2CD1381 NP-specific
memory responders clearly dominates the early phase of the
splenic memory response, then declines rapidly during the
first 2 wk (Fig. 1, B and C, top panels). The B2201/2
CD1381 subset is consistently represented at very low lev-
els into the quiescent phase of the splenic response (day
42). A second subset of NP-specific memory responders
expressed high levels of B220 and no CD138 (Fig. 1 B,
top). These memory responders also reached peak levels
early (day 4), but gradually declined during the first 2 wk
after rechallenge (Fig. 1 C, top). A small compartment of
Figure 1. Three major sub-
sets of NP-specific memory B
cells. Previously primed C57BL/6
mice, rechallenged with 400 mg
NP-KLH in Ribi adjuvant, were
killed at various times after recall
to label spleen and bone marrow
cells for five-color flow cytome-
try. (A, i and ii) PI labeling is ex-
cluded at time of acquisition.
One example of light scatter pa-
rameters and Cy5PE labeling
(anti-CD4, anti-CD8, and anti-
F4/80) used to exclude T cells,
macrophage, and cells that non-
specifically label with Abs. Light
scatter gates are broad to include
B cell blasts. (A iii) Examples of
IgD (Texas red 11.26) and NP
(NP-APC) labeling on the
Cy5PE2 cells. Days after recall
are displayed above each pair of
panels. The top panels are
spleen, and the lower are bone
marrow. Each upper left quad-
rant delineates fluorescence in-
tensities of cells regarded as
NP1IgD2. (A iv) Cellular dy-
namics of the total NP-binding
B cell compartment. Frequencies
of NP-binding IgD2 B cells ob-
tained by flow cytometry, and
total cell numbers from the
spleen (top) and bone marrow
(bottom) of each animal at the
time of killing were used to esti-
mate the change in total NP-
binding cells during the course
of the recall response. Varying
numbers of single animals were
used for each time point (n 5
3–7), with mean 6 SEM of total
cells displayed. (B) Examples of
CD138 (PE-281.2) and B220
(FITC–RA3-6B2) levels on NP-
specific B cells (CD42CD82F4/
802IgD2NP1) of the spleen
(top) and bone marrow (bot-
tom). The day after Ag adminis-
tration is displayed above each
panel. (C) Cellular dynamics of the three NP-binding B cell subsets, with the phenotype displayed above each panel for the spleen (top) and bone mar-
row (bottom). Mean 6 SEM of total cells is displayed across time after recall (n 5 3–7 for each time point). (D) CD4,2 CD8,2 and F4/802 NP1IgD2 B
cells with the phenotype B2201/2CD1381, B2201CD1382, and B2202CD1382 B cells from the spleen and bone marrow (BM) of the secondary re-
sponse were sorted at 50 cells per well into NP-specific IgG-revealing ELISPOT assays. Positives were scored manually under a dissection microscope.
Each assay was done in triplicate from at least three separate animals.1153 McHeyzer-Williams et al.
B2201CD1382 memory B cells also persisted into the qui-
escent phase. The third major subset of NP1IgD2 memory
responders expressed negligible levels of both B220 and
CD138. These Ag-binding memory responders emerged in
the spleen as rapidly as the other two subsets, but clearly
dominated the Ag-specific compartment by the end of the
first wk after rechallenge (Fig. 1, B and C, top panels). The
quiescent memory compartment of the spleen was also
dominated by far greater numbers of the B2202CD1382
memory cells (75–85% of NP1IgD2 cells at day 42). Thus,
the NP-specific memory responders emerge as three phe-
notypically distinct NP1IgD2 subsets that all persist into
the quiescent phase with the B2202CD1382 subset clearly
dominating by the end of the first wk after recall.
B2202CD1382 NP-specific Memory Cells Dominate the
Bone Marrow Compartment. The long-lived Ab-secreting
memory B cell compartment resides mainly in the bone mar-
row (38–42). These previous studies have focused on the bone
marrow compartment after initial priming. To characterize the
memory response, we next quantified the extent and kinetics
of Ag-binding cells that emerged in the bone marrow after re-
call (Fig. 1 A, bottom panels). There was evidence of a decline
in the basal levels of NP-binding cells at day 3, followed by a
rapid rise by day 4 that reached maximal levels by day 9 (Fig.
1, A iv, bottom). The numbers of NP1IgD2 cells remained
remarkably stable between the end of the second wk after re-
challenge and into the quiescent memory compartment (day
42). Strikingly, the B2202CD1382 subset comprised of the
vast majority of NP1IgD2 cells in the bone marrow through-
out all stages of the emergent response and into the quiescent
phase (.95–98% across all time points; Fig. 1 B, bottom). The
B2201/2CD1381 memory responder subset is consistently
present but poorly represented in the bone marrow, whereas
the B2201CD1382 subset is equally low but more sporadic
than its CD1381 counterpart (Fig. 1, B and C, bottom pan-
els). Therefore, the NP-specific memory response in the bone
marrow is dominated by the B2202CD1382 subset that
emerges and persists long term as a significant reservoir of qui-
escent memory B cells.
Ab-secreting Activity Assorts into the B2201/2CD1381 NP-
binding Compartment. CD138 reliably labels Ab-secreting
B cells in the primary NP-specific response (11, 34). To
further evaluate the function of the three different NP-
binding subsets, we sorted equal numbers of purified NP-
binding subsets into ELISPOT assays for production of
NP-specific IgG. In the absence of any stimulus in vitro,
the ELISPOT estimates the frequency of cells secreting Ab
in vivo. All NP-specific IgG Ab-secreting activity assorted
into the splenic B2201/2CD1381 memory B cell compart-
ment during the first 2 wk after rechallenge (Fig. 1 D). Al-
though the B2201 and B2202 NP-binding compartment
expanded significantly on rechallenge, cells with this phe-
notype did not produce Ab during the first 2 wk after re-
call. In the bone marrow, the dominant NP-binding com-
partment (B2202) did not produce Ab during this same
period (Fig. 1 D). Thus, NP-binding cells that differentiate
into Ab-secreting cells during the memory response in vivo
express the B2201/2CD1381 phenotype.
Molecular Characterization of Memory B Cells. The  l L
chain is dominantly expressed in primary and memory re-
sponses to NP-KLH (11, 33, 45). We next screened all
three NP-binding subtypes for expression of this L chain.
Only z5% of all naive B cells in C57BL/6 mice express
the l L chain (Fig. 2 A, top), whereas all three NP-binding
B cell subsets in the spleen contained 90–95% l1 cells (Fig.
2 A, bottom three histograms). Levels of l expression were
similar on all three NP1IgD2 subsets, and were consistent
with the loss of sIgD at the time of original Ag experience.
The frequency of l1 cells and the level of l expression on
the NP1IgD2 cells in the bone marrow was similar to that
seen in the spleen (data not shown). The l expression of-
fers further evidence that all three subpopulations are NP-
specific B cells. The absence of k L chain expression on
these l1 NP-binding B cells also argues against an FcR-
mediated binding of Ab in vivo that leads to artificial label-
ing with NP-APC for flow cytometry (naive NP2 B cells,
k mean fluorescence index [MFI] 5 57; l1 cells, k MFI 5
10; NP1 cells in spleen, k MFI 5 12; NP1 cells in bone
marrow, k MFI 5 13).
Although all three subsets were NP-specific B cells, it
was not clear that they were all memory B cells. One cardi-
nal hallmark for B cell memory is the expression of somati-
cally-mutated Ig with evidence for Ag-driven selection.
We next sorted single cells from each of the three major
subsets for RT-PCR and DNA sequence analysis directed
at the l L chain. PCR products from individual reactions
were then sequenced to assay for somatic mutation. All
three subsets of NP-specific memory responders emerged
similarly mutated by days 3 or 4, and did not significantly
alter in extent of mutation by day 9 after rechallenge (Fig.
2, B and C). A high frequency of replacement mutations in
hypervariable regions 1 and 2 was also consistent with Ag-
driven selection. These changes most likely occurred dur-
ing the induction phase of memory after initial Ag priming
for all three subsets. These data argue against the adsorption
of NP-binding Ab on the cells labeled as NP-specific by
flow cytometry. NP-specific cells in the bone marrow had
similar levels of l L chain mutations (Fig. 2 C). The effi-
ciency of obtaining a PCR product across the three subsets
was 60% for CD1381 cells, 30% for B2201 B cells, and
15% for B2202 B cells (range from 5–50% for the latter).
We attributed these differences to varied mRNA levels,
and they are similar to differences observed between TCR-a
and TCR-b chains from single Ag-specific T cells (52, 53).
Therefore, all three subtypes of NP-specific memory re-
sponders not only express the mRNA for the appropriate L
chain, but also express it in a somatically mutated form
with evidence for Ag-driven selection.
Proliferative Capacity and Ab-secreting Potential of Quiescent
Memory B Cells. Although the B2201/2CD1381  mem-
ory subset was mainly Ab-secreting cells (Fig. 1 D), the
function of the NP-specific B2201 and B2202 memory re-
sponders and their relationship to each other was still not
clear. The only definitive way to address function was
through adoptive transfer and challenge with Ag. We first
focused on day 42 after recall in the quiescent memory1154 Antigen-specific B Cell Memory
phase and adoptively transferred unfractionated spleen cells
(4.0 3 107 cells) with soluble Ag into Rag-1–deficient
mice. 5 d later, all three NP-specific subpopulations of
memory responders were recovered from the recipient
spleens (Fig. 3 A). The majority of NP-specific cells recov-
ered were the B2202CD1382 memory subset (48%), with
fewer B2201/2CD1381 (30%) and B2201CD1382 (22%)
cells present (Fig. 3 D). The recovery of NP-specific B cells
was 250-fold greater, and the production of NP-specific
IgG 300-fold higher in the presence of Ag than without
(Fig. 3 E). Interestingly, the B2201CD1382 subset was the
only fraction to survive in the absence of Ag, although cell
numbers were very low (Fig. 3 A). These data indicate that
cell expansion after transfer was not due to the absence of
lymphocytes in the Rag-1–deficient recipients but was
driven by Ag. Hence, Rag-1–deficient mice can support
the survival and expansion of all three subtypes of NP-spe-
cific quiescent memory B cells and promote the production
of NP-specific IgG.
To transfer purified subsets of nonsecreting NP-specific
memory B cells, we needed to provide a source of Ag-spe-
cific T cell help. We next sorted spleen cells from day 42
Figure 2. All three NP-spe-
cific subsets express somatically
mutated Vl1 L chains. (A) Rep-
resentative histograms of l1 L
chain expression (FITC-JC5) on
CD42, CD82, and F4/802 cells
that were also NP2IgD1B2201
(first panel),  NP1IgD2B2201/2
(second panel), NP1IgD2B2201
(third panel), and NP1
IgD2B2202  (fourth panel). (B)
A summary of the extent and
pattern of somatic hypermuta-
tion in the l1 L chain expressed
by the three major subsets of
NP-specific B cells (PI2CD42
CD82F4/802NP1IgD2). Single
NP-specific B cells from each of
the three subpopulations of cells
(as defined in the legend to Fig.
1) at different time points of the
recall response were sorted into
cDNA reaction mix, subjected
to two separate rounds of PCR
for l L chain and PCR products,
sequenced as described in Mate-
rials and Methods. Day of re-
sponse refers to time after rechal-
lenge; # cells refers to the
number of l L chains sequenced
from individual cells and the
proportion that were mutated
versus nonmutated; % total rep-
resents the percentage of the to-
tal base pairs sequenced that
were mutated (reliable sequence
from position 26–88 for all sam-
ples), with the average number
of mutations per mutated se-
quence summarized in the next
column; and the % replacement
mutations in the CDR1 and 2
are presented in the final col-
umn. (C) A representative set of
Vl gene nucleotide and pre-
dicted amino acid sequence
obtained from individual NP-
specific B cells. Only the nucleo-
tides differing from the germline
V-J sequence are presented:
dashes represent identity; CDR 1
and 2 are boxed. The cells are
grouped into four categories,
with each representing sequence from individual cells with the phenotype of the following: the upper panel is NP1IgD2 B2201/2CD1381 B cells (la-
beled B1/2) from days 3 and 5; the second panel is NP1IgD2B2201CD1382 B cells (B1) from day 4; the third panel is NP1IgD2B2202CD1382 B cells
(B2) from the spleen or bone marrow (bm) from day 4 and 5; and the bottom panel is NP1IgD2B2202CD1382 B cells (B2) from day 9 spleen.1155 McHeyzer-Williams et al.
Figure 3. Adoptive transfer of
purified quiescent B2201 and
B2202 memory B cells. (A) 4 3
107 unfractionated spleen cells
from animals 42 d after rechal-
lenge were injected into the tail
vein of Rag-1–deficient ani-
mals, with or without intraperi-
toneal injection of 50 mg NP-
KLH (no adjuvant). The first
panel represents the NP and IgD
profiles of PI2, CD42, CD82,
and F4/802 spleen cells before
transfer (percentage of NP-spe-
cific cells in total spleen cells is
indicated above the insert). The
second panel represents the
CD138 and B220 profiles of the
NP-specific  cells in these ani-
mals. The third panel represents
the NP and IgD profiles of the
PI2, CD42, CD82, and F4/802
spleen cells from Rag-1–defi-
cient mice 5 d after transfer. The
fourth panel represents the
CD138 and B220 profiles of
these NP-specific cells (1 or 2
Ag as labeled). (B) The first two
panels present reanalysis of
spleen cells from day 42 memory
mice, excluding NP1IgD2 and
all CD1381 cells at the time of
sorting. 5–8 3 106 spleen cells
sorted this way (NP2 spleen)
were injected into the tail vein
(with Ag intraperitoneally as
above), and spleen cells from
Rag-1–deficient recipients ana-
lyzed 5 d after transfer (third and
fourth panel). (C) 2–6 3 104 pu-
rified NP1IgD2CD1382 that
were either B2201 (.95% puri-
fied; top) or B2202 (.99% puri-
fied; bottom) were added to
5–8 3 106 NP2 spleen cells be-
fore adoptive transfer. The first
two panels in each set display re-
analysis of cell populations to be
transferred after addition of the
purified memory subset. The third
panel displays (PI2, CD42, CD82,
and F4/802 NP and IgD cells in
Rag-1–deficient recipients 5 d
after transfer, with the frequency
of NP1IgD2 cells in the total
spleen indicated above inset. The
last panel displays CD138 and
B220 profiles for NP1IgD2
spleen cells in the Rag-1–defi-
cient recipients 5 d after transfer.
(D) Mean of two adoptive trans-
fer experiments displaying the
proportion of the three subsets
recovered after transfer. The
level of NP1 events after transfer of the NP2 spleen cells alone was negligible, so they are not included in this table. (E) Summary of cell recovery and Ab
production during time of transfer (n 5 2 or 3 animals). Cell recovery was calculated as the percent of NP-specific cells recovered over the number trans-
ferred. N/A indicates not applicable, as the number of NP-specific cells transferred and recovered was negligible. The relative titer of NP-specific Ab is
displayed as the titer of serum that produced an OD of 1.4 OD units (maximum of 4.0 OD units).1156 Antigen-specific B Cell Memory
after recall excluding all CD42, CD82, and F4/802
NP1IgD2 B cells before adoptive transfer into Rag-1–defi-
cient mice (Fig. 3 B). We also excluded all CD1381 cells to
minimize the transfer of sIg2 plasma cells. This “back-
ground” NP2 spleen transfer aims at providing the requi-
site T cell help without contributing to the cellular or hu-
moral NP response in recipients. 5 d after transfer with Ag,
the recipient mice showed a significant reconstitution of
IgD1B2201 B cells (Fig. 3 B) and CD4 and CD8 T cells in
the spleen (data not shown). Importantly, very few NP-
specific cells were transferred in the NP2 spleen cells, and
negligible numbers of NP-specific B cells were recovered
after transfer in recipient (Fig. 3 E). In addition, negligible
NP-specific IgG was detected in the recipient serum (Fig. 3
E). We next sorted 4–6 3 104 of either memory B cell sub-
set (B2201 or B2202), mixed each purified memory subset
with the background populations of NP2 spleen cells (5–8 3
106 cells total), and reanalyzed the samples immediately
before transfer (Fig. 3 C; first two panels in each row). 5 d
after transfer, recipient spleens were analyzed for the fre-
quency of NP-specific B cells, the balance of the three
memory B cell subsets, and the production of NP-specific
IgG in vivo (Fig. 3, C–E).
5 d after transfer, B2201 NP-specific memory cells pro-
duced mostly B2202CD1382  NP-specific cells (66%),
with some B2201/2CD1381 Ab-secreting B cells (20%)
and a few B2201CD1382 cells (14%; Fig. 3, C [top] and
D). B2202 NP-specific memory cells produced mostly
B2202CD1382  cells (47%) and B2201/2CD1381  Ab-
secreting cells (38%) and few B2201CD1382 cells (14%; Fig.
3, C [bottom] and D). Thus, the pattern of cellular differ-
entiation on transfer was consistent with progressive linear
differentiation between the B2201, B2202, and CD1381
memory B cells. This progression of differentiation appears
dependent on Ag in this short-term adoptive transfer assay.
Interestingly, cell recovery after transfer of the B2201 cells
was 15-fold higher than after transfer of the B2202 cells
(670% vs. 39%; Fig. 3 E), In striking contrast, the amount
of Ab in the recipient serum after 5 d was 25-fold greater
after transfer of the B2202 cells than the B2201 cells (500
vs. 20 relative titer; Fig. 3 E). These data would suggest
that the B2201 memory B cells retain greater proliferative
capacity than their downstream B2202 memory B cell
counterparts. The ability of the B2202 memory B cells to
produce greater amounts of Ab during the same span of
time indicates a greater degree of commitment towards
plasma cell differentiation than the B2201 cells. These
functional data are consistent with the linear differentia-
tion of B2201 memory B cells into B2202 memory B cells
that in turn terminally differentiate into Ab-secreting cells.
Cellular Differentiation during the Emerging Memory Re-
sponse. To further test this model of linear differentia-
tion, we turned to the emerging phase of the memory re-
sponse. Using an identical experimental design to the day
42 transfers, we transferred unfractionated spleen cells
from animals 4 d after recall into Rag-1–deficient mice
(Fig. 4 A). 5 d after transfer, all three subsets of memory
responders were present in the recipient spleens; however,
exogeneously added Ag was not required for subset recon-
stitution (Fig. 4, A, D, and E). In the absence of added Ag,
only 1% cell recovery was achieved, compared with 60%
with Ag (Fig. 4 E). The presence of added Ag appeared
more necessary for cell recovery than for production of Ab
(Fig. 4 E). In the unfractionated spleen cell transfer at day
4, a high number of terminally differentiated Ab-secreting
cells are present in the transfer, and some level of Ag is
most likely also transferred at this acute stage of the mem-
ory response. Nevertheless, as with day 42, all NP activity
was excluded with the exclusion sorting procedure de-
scribed previously and resulted in no detectable NP-spe-
cific cell expansion or serum IgG production 5 d after
transfer (Fig. 4, B and E). We also transferred 50 ml of se-
rum from mice 9 d after recall into Rag-1–deficient recip-
ients, then assayed for appearance of NP-binding cells 24 h
after transfer to see if there were any cells in the recipients
that could trap the NP-specific Ab and then score as NP-
binding B cells after transfer. An average of 1:108,000
events (6 20,000; n 5 3, 6 SEM) in the spleen and 1:500,000
events in the bone marrow (all three animals were iden-
tical) argues against nonspecific FcR-mediated binding.
Compared with the day 42 transfer, the same general
pattern of cellular differentiation was observed after trans-
fer of purified memory B cell subsets 4 d after rechallenge.
When purified B2201 memory responders were trans-
ferred, the major cellular products were NP-specific
B2202 (46%) and CD1381 cells (37%), with few remain-
ing B2201 cells (17%; Fig. 4, C and D). When B2202
memory responders were transferred, mostly B2202 cells
were produced (49%), with similar numbers of CD1381
cells (40%) and a minority of B2201 cells (11%; Fig. 4, C
and D). However, total cell recovery and Ab production
was lower after transfer of day 4 memory responders than
after transfer of the quiescent memory B cells (Fig. 4 E).
These differences may reflect different growth require-
ments for NP-specific memory cells in the emergent com-
pared with quiescent phase in vivo. Nevertheless, the
B2201 memory responders demonstrated slightly higher
proliferative capacity than their B2202 counterparts, and
the B2202 cells produced slightly higher NP-specific IgG
upon transfer (Fig. 4 E). Thus, it appears that the cellular
differentiation pattern displayed after transfer of the day 42
quiescent memory cells may already be established by day
4 of the memory response.
B2202CD1382 Memory B Cells Express a Unique Cell
Surface Phenotype. Consistent with a stable change in dif-
ferentiation between the B2201 and B2202 memory B
cells, a change in cell surface phenotype may indicate dif-
ferent means for responding to Ag and differential activa-
tion requirements. CD45 modulates BCR signal transduc-
tion and appears downregulated on both B2202 memory
B cells and CD1381 Ab-secreting B cells. The mAb RA3-
6B2 (used in the current studies) recognizes the B cell iso-
form of CD45 (B220) through its expression of exon A
and specific carbohydrate residues (54). In contrast, the
mAb 30-F11 recognizes CD45 regardless of isoform. Us-
ing 30-F11 expression, all NP-specific memory B cell sub-1157 McHeyzer-Williams et al.
sets appear to express CD45 to similar levels (Fig. 5, left).
Thus, the B2202 (RA3-6B22) and CD1381 memory B
cells have an isoform or glycosylation variant of CD45,
suggesting alternate ligands or functions for this molecule
across different memory B cell subsets.
CD19 is another typical B cell lineage marker known to
positively regulate BCR signal transduction and decrease
on differentiation to Ab-secreting cells (55). Resting B
cells and NP-specific B2201 memory cells express CD19
to similar levels (Fig. 5, right). However, CD19 is down-
regulated on the NP-specific B2202 memory B cell com-
partment. Expression of CD19 is two- to threefold lower
than that expressed on the B2201/2CD1381 Ab-secreting
memory compartment, and is similar to background levels
Figure 4. Adoptive transfer of purified
emergent B2201 and B2202 memory B
cells. (A) 4 3 107 unfractionated spleen cells
from animals 4 d after rechallenge were in-
jected into the tail vein of C57BL/6 Rag-
1–deficient animals by intraperitoneal injec-
tion with 50 mg NP-KLH (no adjuvant).
The first panel represents the NP and IgD
profiles of the spleen cells that were trans-
ferred. The second panel represents the
CD138 and B220 profiles of the NP1IgD2
cells in these animals (percentage of NP-
specific cells in total spleen cells before
transfer is indicated above inset). The per-
centage of NP1IgD2 cells after transfer (of
total spleen cells in recipient) is displayed in
the next column, and the third panel repre-
sents the CD138 and B220 profiles of the
NP1IgD2 cells in the spleens of the Rag-1–
deficient mice 5 d after transfer. (B) The
first two panels present reanalysis of spleen
cells from day 4 memory mice, excluding
NP1IgD2 and all CD1381 cells at the time
of sorting. 5–8 3 106 spleen cells sorted this
way (NP2 spleen) were injected into the
tail vein (with Ag intraperitoneally as
above), and spleen cells from Rag-1–defi-
cient donors analyzed 5 d after transfer
(third panel). (C) 2–6 3 104 purified
NP1IgD2CD1382 that were B2201 (top)
or B2202 bottom) were added to 5–8 3
106 NP2 spleen cells before adoptive trans-
fer. The first two panels in each set are the
reanalysis of the cell mixture immediately
before transfer, and in the last panel are the
CD138 and B220 profiles of the
NP1IgD2spleen cells in the Rag-1–defi-
cient recipients 5 d after transfer. (D) Mean
6 SEM from three adoptive transfer experi-
ments displaying the proportion of the three
subsets recovered after transfer. The level of
NP1 events after transfer of the NP2 spleen
cells alone was negligible, so they are not
included in this table. (E) Summary of cell
recovery and Ab production during time of
transfer (n 5 2 or 3 animals). Cell recovery
was calculated as the percent of NP-specific
cells recovered divided by the number
transferred. N/A indicates not applicable, as
the number of NP-specific cells transferred
and recovered was negligible. The relative
titer of NP-specific Ab is displayed as the ti-
ter of serum that produced an OD of 1.4
OD units (maximum of 4.0 OD units).1158 Antigen-specific B Cell Memory
on T cells (Fig. 5, right). The absence of CD19 may indi-
cate hyperresponsiveness to BCR signal transduction.
Consistent with different Ag-receptor signaling potentials,
CD22, CD23 (the low affinity FceR), CD24, and CD38
were also absent on the B2202 memory B cells, whereas
CD43 was markedly upregulated (data not shown). The
absence of CD5 (data not shown) indicated that the NP-
specific B2202 subset did not belong to the B1a B cell
subtype (56). Overall, the cell surface phenotype for the
B2202 memory B cells is unique and predicts a very differ-
ent mechanism of Ag receptor–mediated signal transduc-
tion.
Two Major Subsets of B2202 Memory B Cells. Although
coreceptor expression offers clues to Ag responsiveness,
integrin expression highlights differences in the interaction
with the microenvironment, and perhaps unique migra-
tion patterns. CD11b expression not only distinguishes the
B2202 memory B cells from the CD1381 and B2201
memory B cells, but also divides the B2202 memory B
cell compartment into two major subsets (Fig. 6 A).
CD11b expression on the NP-specific B2202 memory
compartment is best viewed in the bone marrow (where
the B2202 B cells dominate) against sIgE expression (Fig.
6 A; bottom right). The NP-specific B2202 B cells clearly
divide into two major subsets, CD11b11IgE2 and
CD11b1IgE1. These two subsets are also present within
the NP-specific cells of the spleen (Fig. 6 A; middle right
panel). When CD11b and IgE labeling is paired sepa-
rately with B220 and CD138 in splenic samples, the
CD11b11 and IgE1 cells appear clearly contained within
the NP-specific B2202 memory compartment (data not
shown). Both the CD11b11 and IgE1 B2202 subsets are
isotype switched and negative for sIgM (data not shown).
Although there is a high level of background labeling with
anti-IgG on naive B cells and the IgE1 subset (Fig. 6 B),
the CD11b11IgE2 subset express sIgG at 20-fold higher
levels, comparable to levels on B2201 and CD1381 NP-
specific cells (Fig. 6 B). The sIgE1 cells are not secreting
NP-specific IgE as assessed by an ELISPOT assay (data not
shown). Both NP-specific B2202  subsets are present
throughout the memory response and into the quiescent
memory phase; however, the balance of cells within each
subset is variable (data not shown). Nevertheless, sIgE ex-
pression is only found in the B2202 compartment and
provides a clear example of commitment to subspecialized
function among the long-lived B2202 memory B cells.
The light scatter properties of the four different memory
responders at day 9 after recall are displayed in Fig. 6 C.
All NP-specific memory B cell subsets have higher obtuse
light scatter and are larger by forward light scatter than
resting B cells, but have lower obtuse light scatter than to-
tal CD11b11 cells in the spleen. Thus, the CD11b11 B
cells are not representative of all CD11b11 cells in the
spleen (which are mostly macrophage). To further investi-
gate the morphology of this unique memory B cell com-
partment, we selected CD11b11 memory cells 9 d after
recall for transmission electron micrographs (TEMs; Fig. 6
D). Many of the CD11b11 cells scanned had typical rest-
ing lymphoid ultrastructure (z20%; n 5 100), with
rounded nucleus and scant cytoplasm (Fig. 6 D, i). An-
other fraction appeared lymphoblastoid (z15%), with a
more ovoid nucleus, loose chromatin, and more abundant
cytoplasm (Fig. 6 D, ii). The majority of NP-specific
CD11b11 cells (z65%) contained the more rounded nu-
cleus typical of a lymphocyte, but with a notch (Fig. 6 D,
iii). Thus, the B2202 memory B cells share many typical
physical characteristics of lymphocyte, with some unique
ultrastructural features in the CD11b1 subtype.
CD79b Expression Divides B2202 Memory B Cell Com-
partment. Finally, we address the expression of the BCR
signaling complex subunit CD79b (Igb) across all NP-
binding B cells (Fig. 7). High levels of CD79b are ex-
pressed on resting B cells, the B2201 memory B cells, and
the CD11b11IgE2 memory B cell subset. The level of ex-
pression appears progressively lower between the resting
state B2201 and B2202CD11b11 cells, but to levels 10-
fold above background. Nevertheless, the CD79b expres-
sion represents the first typical and characteristic B cell Ag
expressed on the CD11b11IgE2 subset. In contrast, the
NP-specific CD1381 and IgE1 subsets express CD79b
Figure 5. B2202CD1382 memory B cells express an alternate form of
CD45 and no CD19. Representative histograms for CD45 (FITC–30-
F11) and CD19 (FITC-1D3) on CD42, CD82, and F4/802 cells that
were also IgD1NP2B2201 B cells (first row), IgD2NP1CD1381 (second
row), IgD2NP1B2201 (third row), and IgD2NP1B2202 cells from the
spleen (fourth row) and bone marrow (fifth row). Where pertinent, levels
of labeling for “T cells” (the majority of Cy5-PE1 are CD4 and CD8 T
cells), CD452IgD2NP2B2202 cells are also displayed in the first row.
All displays are from the same animal at day 9 of the recall response and
are representative of three to eight animals. The dashed lines within each
histogram and the number associated depict the geometric mean fluores-
cence for the reagent presented.1159 McHeyzer-Williams et al.
Figure 6. Two major subsets of NP-spe-
cific B2202 memory B cells. (A) Represen-
tative profiles of CD138 and B220 (first
column) and CD11b and IgE (second col-
umn) on CD42, CD82, and F4/802 cells
that were also NP2IgD1  (first row),
NP1IgD2 spleen (second row), and
NP1IgD2 bone marrow (third row). (B)
Histograms for anti-IgG labeling on total
CD11b11NP2IgD2 (top, black), small for-
ward/side scatter Cy5PE1 cells (mostly T
cells; top, gray), NP2IgD1B2201 (resting B
cells; middle, gray), NP1IgD2CD11b2
(NP-specific B2201/2 and B2201; middle,
black), NP1IgD2CD11b11 (bottom, black),
and NP1IgD2CD11b1IgE1 (bottom, gray).
Cells were labeled with PE–anti-IgG,
blocked with normal mouse serum, and
then labeled with mAbs as described. (C)
Representative profiles for forward and ob-
tuse light scatter on CD42, CD82, and
F4/802 cells that were also NP2IgD1
B2201 (resting B cells; top left), NP1
IgD2CD1382B2201 (B2201; top middle),
NP1IgD2CD11b11IgE2 (CD11b11; top
right), NP1IgD2CD11b1IgE1 (IgE1; bot-
tom left), NP1IgD2CD1381B2201/2
(CD1381; bottom middle), and CD11b11
NP2IgD2 (total CD11b11; bottom right).
(A–C) Profiles are from day 9 of the recall
response and are representative of three to
nine animals. (D) TEM of CD42, CD82,
and F4/802 NP1IgD2CD11b11IgE2 spleen
cells from day 9 recall response. 1.2 3 105
cells were sorted into 2% glutaraldehyde
and processed for TEM by Duke Compre-
hensive Cancer Facility. Images are repre-
sentative of at least 100 individual
CD11b11 NP-specific cells scanned.
levels only marginally above background (Fig. 7; T cells).
The low levels of CD79b on Ab-secreting cells may be
consistent with terminal differentiation and the reduced
need to respond to Ag. The loss of CD79b on the nonse-
creting IgE1 cells is not understood, but indicates very dif-
ferent Ag responsiveness across different Ig isotypes in the
B2202 memory B cell compartment. Thus, cellular poten-
tials on transfer, levels of coreceptor and integrin expres-
sion, pattern of Ig isotype, and signaling subunits assort
NP-specific memory B cells into four separate cellular
compartments, each with unique roles in the maintenance
of long-term protective immunity.
Discussion
In this study, we quantitatively analyze the emergence of
Ag-specific memory B cell responders and the subsequent
reestablishment of the quiescent memory B cell compart-1160 Antigen-specific B Cell Memory
ment. We reveal a novel B2202 memory B cell compart-
ment that constitutes a significant component of the mem-
ory response to Ag and forms the major cellular reservoir of
B cell memory in both the spleen and the bone marrow.
Upon Ag rechallenge, the B2202 memory B cells rapidly
self-replenish, but also differentiate into Ab-secreting cells
with high efficiency. The B2201 memory B cells also func-
tion as memory response precursors, but mainly differentiate
into B2202 memory B cells upon Ag rechallenge. All
B2202 memory cells have isotype switched and divide
broadly into two subsets, CD11b11IgG1 and CD11b1
IgE1. Both B2202 subsets differ markedly in coreceptor ex-
pression from either naive B cells or B2201 memory B cells.
This cell surface phenotype predicts differential activation
requirements and provides unique means for regulating the
response to Ag rechallenge in vivo. Taken together, these
data highlight the complex organization of B cell memory
into cellular compartments with distinct patterns of regula-
tion and subspecialized immune function.
Expression of B Cell Memory. We chose to analyze the
emergent memory response to Ag as one way to quantify
the activity of memory B cells directly ex vivo. Ideally,
memory B cell expansion to Ag rechallenge would lead to
the rapid formation of Ab-secreting cells and the replenish-
ment (or preservation) of the memory B cell compartment.
Ab-secreting cells emerge first in the T cell zones of the
spleen during a primary response (5, 57) and express high
levels of CD138 (11, 34). In the memory response,
NP1IgD2B2201/2CD1381 cells emerge rapidly to levels up
to 10-fold greater than that seen after initial priming (11).
B2201 memory B cells also appear in response to recall. Ag-
binding isotype-switched B cells with this phenotype at late
time points after initial priming can be regarded as quiescent
memory B cells (13, 30, 31, 58). After Ag recall in vivo, iso-
type-switched B cells with the B2201 phenotype cannot be
distinguished from B cells that have initiated a secondary
GC reaction (5, 8, 59, 60). Nevertheless, accelerated expan-
sion of both B2201/2CD1381 and B2201CD1382 memory
B cells is a major cellular consequence of Ag rechallenge.
The appearance of a major subset of B2202CD1382 Ag-
binding B cells was unexpected. These NP-binding B2202
cells expanded rapidly and specifically in response to Ag re-
challenge, expressed somatically-mutated BCRs, and were
not secreting Ab in vivo. The adoptive transfer experiments
4 d after recall provide the clearest insights into the role of
these B2202 cells in the emerging memory response (Fig.
4). They arose from purified B2201CD1382 precursors on
transfer, but could also self-replenish with high efficiency
when transferred on their own. Besides self-replenishment,
they predominantly produced Ab-secreting cells but still re-
tained some ability to produce B2201 memory cells on
transfer.
Further insight into the distinct function of the B2202
cells was offered through integrin and Ig isotype expression
(Fig. 6). The B2202 compartment divided into CD11b11
and CD11b1 subsets, both distinguishable from the other
two memory subsets (CD11b2). There have been reports
for expression of CD11b on both activated T cells (61) and
subsets of splenic B cells (62). CD11b has also been de-
scribed on the B-1 B cell lineage (56), at levels lower than
on the sIgE2 subset. CD11b/CD18 is also known as com-
plement receptor type 3 and may provide an alternate core-
ceptor for the BCR (63, 64). In our earlier studies, CD11b
binding was used to exclude cells such as macrophages from
the analyses of the NP-specific B cell response (11, 33, 34)
and explains why we had not previously revealed the B2202
memory subset. IgG expression was dominant in B2201,
CD1381, and CD11b11 NP-specific subsets. In contrast,
sIgE1 memory cells were only found in the B2202CD11b1
subset. Interestingly, IgE was not detected in the serum of
recipient animals after adoptive transfer of day 4 or 42
memory B cells, suggesting that the secretion of this isotype
is tightly regulated in vivo. Although the BCR signaling
subunit was expressed at high levels in the CD11b11IgG1
compartment, it was absent in the IgE1 cells. Therefore, we
describe two functionally distinct subtypes of the B2202
memory B cells that emerge in response to Ag recall.
B Cell Memory in the Bone Marrow. The predominance
of the B2202CD1382 memory B cells in the bone marrow
was also unexpected. Much of the high affinity Ab that
persists in the serum comes from long-lived Ab-secreting B
cells that reside in the bone marrow (35–40, 65). When
Figure 7. CD79b expression on NP-specific memory B cells. Repre-
sentative histograms for CD79b on spleen CD42, CD82, and F4/802
cells that were also NP2IgD1B2201 B cells (first column, top),
IgD2NP1CD1381 (first column, middle), IgD2NP1B2201 (first col-
umn, bottom), IgD2NP1CD11b11 (second column, top), bone marrow
IgD2NP1CD11b11 (second column, middle), and IgD2NP1IgE2 (sec-
ond column, bottom). Levels of labeling for T cells (small forward/side
scatter, Cy5-PE1 cells) are also displayed in the first column, top. All dis-
plays are from day 9 recall response and are representative of eight ani-
mals. The dashed lines within each histogram and the number associated
depict the geometric mean fluorescence intensity for CD79b.1161 McHeyzer-Williams et al.
quantified by flow cytometry or ELISPOT analysis, Ab-
secreting B cells were present in the bone marrow at very
low frequencies (41, 42). These frequencies correspond
well to the low frequencies of CD1381 B cells seen in the
bone marrow in this analysis. Nevertheless, in the bone
marrow, .95% of the Ag-specific compartment comprised
of B2202CD1382 nonsecreting B cells. These cells most
likely migrate to the bone marrow from the splenic re-
sponse to Ag and persist there at high levels to at least day
42 after recall. These cells may be the isotype-switched
equivalent to the CD24low somatically-mutated IgM mem-
ory B cells that migrate to the bone marrow in humans
(66). Upon adoptive transfer of NP-specific B cells from
the spleen, B2202CD1382 B cells do appear in the bone
marrow (data not shown), arguing that migration can occur
between these two compartments. The bone marrow and
spleen may contain the appropriate microenvironment for
the long-term survival of B2202CD1382 memory B cell
compartment. Thus, the bone marrow provides an alterna-
tive reservoir for B2202 memory response precursors that
may migrate into the spleen and expand upon Ag rechal-
lenge.
Somatic Hypermutation in the Memory B Cell Compart-
ment. There was no obvious change in the pattern of so-
matic mutation in all three Ag-specific memory responders
during the emergent memory response. Although lower
than typically expected for the VH186.2 (9, 11, 33), the
level of mutation was significant and consistent in the Vl1
L chain for all three memory populations, and was higher
than reported previously for early in the primary response
(day 12; reference 32). All three memory compartments
emerged by days 3–4 in the spleen with already mutated L
chain genes. However, the extent of mutation did not
change by day 9. Although expected for the Ab-secreting
compartment, this is surprising for the B2201CD1382
memory response compartment that most likely constitutes
a secondary GC reaction. It also suggests that the B2202
memory compartment was expanded after recall with no
further diversification and selection. This finding is consis-
tent with the non-GC phenotype of the B2202 compart-
ment, and further implies that expansion of the novel
memory compartment did not require a GC phase after re-
call. These data support the contention that memory B cells
do not further diversify by somatic hypermutation upon Ag
recall (67).
Replenishment of the Memory B Cell Reservoir. The ori-
gin of memory B cells still remains controversial. Jacob and
Kelsoe provide evidence for the branching of GC B cells
and Ab-secreting B cells from common precursors and ar-
gue for a common clonal origin for Ag-specific effector
cells and memory cells (46). In contrast, Klinman and col-
leagues present evidence for a preexisting CD24low lineage
of B cells that act as precursors for the memory response,
have a greater propensity to form GC and do not contrib-
ute substantially to the primary Ab response (68–70). As a
further complication, entry into the memory compartment
appears to be dictated by the affinity of the mutated BCR
relative to its unmutated counterpart (71), and may be de-
rived from only a small fraction of all GCs available (72).
Thus, variability in origins and function of the memory B
cells as well as heterogeneity in their localization and traf-
ficking patterns may complicate the memory B cell com-
partment.
Our analysis of the quiescent memory phase (day 42 after
recall) provides insight into the persistent memory B cell
compartment. B2201 memory precursors do appear in our
studies, and the activity of these cells on adoptive transfer
helps to confirm earlier studies on B2201 memory B cells
(13, 30, 31, 58). However, the B2202 memory B cell com-
partment has not been described previously. Some aspects
of B2202 memory B cell function are reminiscent of the
CD24low memory lineage demonstrated by Klinman and
colleagues (68–70). In the memory response, it is not possi-
ble to distinguish the functions of the CD24low memory B
cells (70), as they appear to form GCs as well as Ab-secret-
ing cells. Although Klinman and colleagues’ more recent
analysis of the memory response suggests multiple activities
within the memory compartment, they associate all mem-
ory function with the CD24low phenotype (70). The
B2202 memory B cells appear to predominantly form Ab-
secreting B cells, and may only form GCs in the absence of
B2201 memory B cells. Further, the B2202 NP-specific
memory B cell subset lacks expression of CD24; however,
the B2201 memory B cell compartment expresses higher
levels of CD24 than found on naive B cells (data not
shown), inconsistent with the notion that all memory is
CD24low (70). The CD24low memory B cells also seem ca-
pable of accumulating somatic mutations during the recall
response (70), an activity that is not apparent in the B2202
memory compartment.
Atypical Coreceptor Expression on B2202 Memory B Cells.
The atypical cell surface phenotype of the novel B2202
memory B cell compartment predicts very different mecha-
nisms for BCR-mediated signal transduction. Although it is
clear that all three Ag-specific B cell populations express
similar levels of CD45, they express different isoforms or
glycosylation variants of the B220 molecule. CD45 posi-
tively regulates BCR signal transduction (73–75) and mod-
ulates positive and negative selection of self-reactive B cells
(76). Although different isoforms of CD45 are thought to
be expressed on memory T cell subsets, their functional
consequence remains unclear. B2202CD192 B cells have
been described by Wabl and colleagues (77, 78) in the
quasimonoclonal mouse model, although their function in
this model remains unknown. In a more recent manuscript,
these B2202CD192 B cells express mutated forms of the
transgenic receptor, arguing for the memory status of these
cells (79). Interestingly, the B2202CD192 B cells from
these transgenic animals do not express CD11b, and hence
may be distinct from the B2202 memory B cells in this
study. CD19 is another BCR response regulator, and is
thought to positively impact on signal transduction (55).
Although it is recognized that CD19 is downregulated on
plasma cells, it was assumed that loss of CD19 is associated
with the loss of sIg, and hence not required on this termi-
nally differentiated cell type. The effect of CD19 downreg-1162 Antigen-specific B Cell Memory
ulation on the B2202 compartment remains unclear; how-
ever, it is clear that these atypical memory B cells can
respond vigorously to Ag in the absence of CD19.
CD5 and CD22 are negative regulators of BCR signal
transduction (80, 81), and their absence may lead to hyper-
responsiveness to Ag triggering in the B2202 subsets. Simi-
larly, CD43 ligation can induce cell cycle arrest and extend
B cell survival in vitro (82, 83). Thus, CD43 upregulation
on the B2202 memory compartment may play a role in the
persistence of these cells in vivo. Expression of CD79b on
the CD11b11 subset suggests that BCR signal transduction
itself may be similar between the B2202CD11b11 and
the B2201 memory compartments, but distinct in the
B2202IgE1 compartment. CD21 expression also appears to
assort between the B2202CD11b11 (intermediate CD21)
and B2202IgE1 (CD21low; data not shown). Overall, the
extensive changes in cell surface phenotype indicate a
change in physiology required for the homeostatic mainte-
nance of memory B cells, or it may indicate hypersensitiv-
ity to Ag recall and a heightened readiness to respond.
B Cell Memory as a Balance of Cellular Subsets. Under-
standing and generating effective B cell memory underpins
all efforts at vaccine design and has the potential to impact
many aspects of fundamental and clinical immunology.
Our studies demonstrate that B cell memory is organized
into at least three cellular compartments. The three main
memory B cell compartments appear to have decreasing
potential for cellular differentiation. B2201 memory B cells
have the highest potential for change, and rapidly produce
B2202 memory B cells with few Ab-secreting cells upon
Ag rechallenge. B2202 memory B cells self-replenish rap-
idly upon Ag rechallenge and produce Ab-secreting cells
with high efficiency, but retain little capacity to produce
B2201 memory B cells. This pattern of differentiation sug-
gests that B2202 memory B cells have an intermediate po-
tential for change. In contrast, Ab-secreting cells are long
lived, terminally-differentiated end stage cells with no po-
tential for change. This schematic broadly indicates a model
of linear differentiation, with B2201 memory B cells pro-
ducing B2202 memory B cells, which in turn produce
CD1381 Ab-secreting cells. This model implies that B cell
memory exists as a complex balance of stable precursors at
differing stages of functional commitment. A parallel model
exists for T cell differentiation in which Ag experience
leads to functional precommitment within subsets of
Ag-specific T cells (84–87). In the T cell compartment,
precommitment allows for rapid expression of preferred ef-
fector functions such as cytokine production. Similar func-
tional expediency may underpin subspecialization within
the memory B cell compartment. Thus, promoting an ef-
fective balance of memory B cell subtypes after priming
would be a critical means for regulating effective long-term
protective immunity in vivo.
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